Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

Authors: Aditya H Gaur, Edmund V Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A Marzinke, Cynthia McCoig, Rodica M Van Solingen-Ristea, Sisinyana Ruth Mathiba, Adeola Adeyeye, John H Moye, Barbara Heckman, Elizabeth D Lowenthal, Shawn Ward, Ryan Milligan, Pearl Samson, Brookie M Best, Conn M Harrington, Susan L Ford, Jenny Huang, Herta Crauwels, Kati Vandermeulen, Allison L Agwu, Christiana Smith-Anderson, Andres Camacho-Gonzalez, Pradthana Ounchanum, Jared L Kneebone, Ellen Townley, Carolyn Bolton Moore, Sarah Buisson, S. Y. Amy Cheung, Vasiliki Chounta, Isabelle Deprez, Alicia Catherine Desmond, Kelong Han, Sherika Hanley, Yu-Wei Lin, Faeezah Patel, Mary E. Paul, Gilly Roberts, Kyle Whitson, Sara Zabih

Published: 2024-03-25

DOI: 10.1016/s2352-3018(23)00300-4

Source: Full article

---

Abstract

No abstract found.